Protein alterations associated with pancreatic cancer and chronic pancreatitis found in human plasma using global quantitative proteomics profiling.
about
Head mass in chronic pancreatitis: Inflammatory or malignantEarly diagnosis of pancreatic cancer: challenges and new developmentsProteomics portrait of archival lesions of chronic pancreatitisBioactive Nutrients and Nutrigenomics in Age-Related Diseases.Combining in Vitro Diagnostics with in Vivo Imaging for Earlier Detection of Pancreatic Ductal Adenocarcinoma: Challenges and Solutions.Quantitative glycoproteomics analysis reveals changes in N-glycosylation level associated with pancreatic ductal adenocarcinoma.Laser Capture Microdissection of Pancreatic Acinar Cells to Identify Proteomic Alterations in a Murine Model of Caerulein-Induced PancreatitisSerum cytokine biomarker panels for discriminating pancreatic cancer from benign pancreatic disease.Advances in acute and chronic pancreatitis: from development to inflammation and repair.N-glycoprotein SRMAtlas: a resource of mass spectrometric assays for N-glycosites enabling consistent and multiplexed protein quantification for clinical applications.Identification and verification of transthyretin as a potential biomarker for pancreatic ductal adenocarcinoma.Automated sample preparation platform for mass spectrometry-based plasma proteomics and biomarker discoveryLong noncoding intronic RNAs are differentially expressed in primary and metastatic pancreatic cancer.Urinary TIMP-1 and MMP-2 levels detect the presence of pancreatic malignancies.Relative quantification of serum proteins from pancreatic ductal adenocarcinoma patients by stable isotope dilution liquid chromatography-mass spectrometry.Multiplex targeted proteomic assay for biomarker detection in plasma: a pancreatic cancer biomarker case study.Proteomics analysis of bodily fluids in pancreatic cancerRole of IL-6 in the resolution of pancreatitis in obese miceFactors influencing receptivity to future screening options for pancreatic cancer in those with and without pancreatic cancer family history.Pancreatic preneoplastic lesions plasma signatures and biomarkers based on proteome profiling of mouse models.Isotope Coded Protein Labeling analysis of plasma specimens from acute severe dengue fever patients.Differential gene expression analysis of peripheral blood mononuclear cells reveals novel test for early detection of pancreatic cancer.Serum biomarkers identification by mass spectrometry in high-mortality tumors.Serum osteopontin and tissue inhibitor of metalloproteinase 1 as diagnostic and prognostic biomarkers for pancreatic adenocarcinomaERK2-regulated TIMP1 induces hyperproliferation of K-Ras(G12D)-transformed pancreatic ductal cells.Serum biomarkers of papillary thyroid canceriTRAQ reveals candidate pancreatic cancer serum biomarkers: influence of obstructive jaundice on their performance.Contributions of immunoaffinity chromatography to deep proteome profiling of human biofluidsProteomics as a systems approach to pancreatitis.Unraveling the sperm proteome and post-genomic pathways associated with sperm nuclear DNA fragmentationGlycoprotein biomarker panel for pancreatic cancer discovered by quantitative proteomics analysis.The role of quantitative mass spectrometry in the discovery of pancreatic cancer biomarkers for translational science.Advances in membrane proteomics and cancer biomarker discovery: current status and future perspective.Premetastatic niche formation in the liver: emerging mechanisms and mouse models.Proteomic strategies in the search for novel pancreatic cancer biomarkers and drug targets: recent advances and clinical impact.Comparative proteomic profiling of the serum differentiates pancreatic cancer from chronic pancreatitis.Revisiting biomarker discovery by plasma proteomics.Silencing IGFBP-2 decreases pancreatic cancer metastasis and enhances chemotherapeutic sensitivity.Sperm nuclear DNA fragmentation rate is associated with differential protein expression and enriched functions in human seminal plasma.Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer.
P2860
Q27011806-760D7B45-78A6-4D5F-A0AF-A76A9723E455Q27014027-C56E2B15-6F60-40B7-94F8-97FC512197C2Q28478126-AD8E2ECC-A5B6-45A7-BDD6-54F304AA11CBQ30239072-8E64F3B4-D8B9-433F-983F-A6DD1806412BQ30368922-CB9A8871-0D3B-4E44-AFE7-DFCD953FC7F6Q30576595-8A1A739A-597F-45E2-A948-B24695109C30Q33635133-A4363896-A02D-42BD-9D53-004F34E71A0AQ33655712-A2164A28-3DA3-4779-86F4-B967B954DAE5Q33896448-29594C0B-13BF-41CF-BFCE-15E8AAAAC2CBQ34585592-6EF0BBF5-659A-4420-8170-CD2DD18911B2Q34644418-0AC5DA6C-E1D8-4AEB-8C4F-13997096EBD7Q35169652-0C9607E9-CC33-4872-ADAA-AEDB6189BFF7Q35576601-3091B577-27B0-43FF-A5A6-D904ECC2CDEDQ35678051-FC5F7653-7207-4D2D-B766-9DEF946D0FA8Q35798915-98A548B5-0FAA-4E74-83D0-F4D53B218A1EQ35798976-CA1E7B2C-7B08-4CC5-AA23-8D2E3C209CEDQ35920900-F1082488-8E46-4D5B-AD11-E4C6C2405BC3Q35988584-1A4CCBF5-511A-451F-B6C1-7E94B4C7738FQ36136686-447F1FC0-8530-4EA6-950C-76A5EEF689D7Q36443870-51537F8D-5EE9-416C-AC1B-D9BDB1C9B01FQ36541688-D76A2712-F1DE-4568-9E67-147CD6AA8E29Q36570435-9692F345-73E9-490F-9E8A-90EA51DC76F8Q36582422-11BFD9D1-DC82-44A1-9CD3-EF47B0546AC2Q36622740-0FFE0A26-B097-45F9-A9CD-1AC83B9B87B8Q36730571-FB7A90D6-F57B-4885-9E29-63EAF0614CEEQ36834893-0B919FFF-7AC9-4706-82C9-1C4764F44000Q36857512-CEFB1E12-6C1A-4C83-B791-B09D8231876FQ36889137-9670B65E-2729-44AA-B3A8-E6B9F6A0D8AEQ37019156-1BCB79BE-2E3E-4787-A0B6-29DEFF684593Q37239531-BA4D64D4-4641-4526-AA73-2B41C329222EQ37714287-01C4D1D9-9AA5-4C1E-8B17-4BF62272BF61Q37720601-A9D0068F-59FE-4336-9E37-7975EE72FA7FQ38034447-2CF0722B-2585-47EB-B698-39C103AABDBEQ38591967-5F2CF191-C9AD-4443-BCC5-EAF51F98857FQ38777938-CEF4BCD8-A69F-4794-858C-56BA01177EECQ40975840-CA7193D6-C271-4C60-A0CB-11F6D1406F75Q41676452-A8A2F5C1-446C-4C97-920F-6F7798303EBBQ42365291-0A91E20F-03D8-492F-9256-50D7A5901B50Q43413893-3515E1D6-7FBE-409B-82CB-226CBEF984DEQ46289482-6306FC59-B20C-4BF5-BDA7-504543325FC1
P2860
Protein alterations associated with pancreatic cancer and chronic pancreatitis found in human plasma using global quantitative proteomics profiling.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Protein alterations associated ...... titative proteomics profiling.
@ast
Protein alterations associated ...... titative proteomics profiling.
@en
Protein alterations associated ...... titative proteomics profiling.
@nl
type
label
Protein alterations associated ...... titative proteomics profiling.
@ast
Protein alterations associated ...... titative proteomics profiling.
@en
Protein alterations associated ...... titative proteomics profiling.
@nl
prefLabel
Protein alterations associated ...... titative proteomics profiling.
@ast
Protein alterations associated ...... titative proteomics profiling.
@en
Protein alterations associated ...... titative proteomics profiling.
@nl
P2093
P2860
P356
P1476
Protein alterations associated ...... titative proteomics profiling.
@en
P2093
David A Crispin
Martin W McIntosh
Mary P Bronner
Teresa A Brentnall
Tyler Stevens
P2860
P304
P356
10.1021/PR101148R
P577
2011-03-28T00:00:00Z